Remifentanil preconditioning reduces post-ischaemic myocardial infarction and improves left ventricular performance via activation of the JAK/STAT signal pathway and subsequent inhibition of GSK3β in rats
Remifentanil is an ultra-short-acting phenylpiperidine opioid analgesic that is rapidly metabolized by nonspecific blood and tissue esterases. In clinical practice, remifentanil is now more commonly used during both cardiac and non-cardiac surgery than classic opioid agonists such as morphine, since...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/207197 |